Prescription Required
Inclusive of all taxes
In Parkinson's disease Tidomet E 50mg/12.5mg/200mg Tablet is a medicine that helps relieve symptoms of Parkinson's disease such as tremors, muscle stiffness and difficulty moving. It increases the amount of a chemical called dopamine in the brain which helps in coordination of body movements. This medicine can therefore enhance the quality of life by improving the ability to carry out daily functions in a better manner.
It is unsafe to consume alcohol with Tidomet E 50mg/12.5mg/200mg Tablet.
Tidomet E 50mg/12.5mg/200mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Tidomet E 50mg/12.5mg/200mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Tidomet E 50mg/12.5mg/200mg Tablet may cause side effects which could affect your ability to drive. Caution is advised when driving or operating machinery.
Tidomet E 50mg/12.5mg/200mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Tidomet E 50mg/12.5mg/200mg Tablet may not be needed in these patients. Please consult your doctor.
Tidomet E 50mg/12.5mg/200mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Tidomet E 50mg/12.5mg/200mg Tablet may be needed. Please consult your doctor.
If you miss a dose of Tidomet E 50mg/12.5mg/200mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)